The abstract is read at the publisher; the summary is JClub's.
Fusion-loop-engineered Zika virus (ZIKV)-M/E mRNA vaccination in macaques protects against ZIKV challenge with negligible dengue virus (DENV) ADE.
- Why it matters: ADE is a key barrier in flavivirus vaccine design, and prior fusion-loop validations in mice may not translate to humans due to strong species differences.
- What they did: Macaques were immunized with FL-engineered ZIKV-M/E mRNA, then B cell specificity and antibody function were profiled, including cryo-electron microscopy mapping of the targeted epitope hotspot.
- The result: Vaccine-elicited B cells were >97% ZIKV-specific, converging on a germline ortholog of human IGHV5-10-1, with antibodies blocking multiple viral entry stages and targeting D67-M68-A69 while DENV N67-linked glycan sterically shields cross-reactivity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.